From Casetext: Smarter Legal Research

Plexxikon Inc. v. Novartis Pharm. Corp.

United States District Court, Northern District of California
Sep 17, 2021
4:17-cv-04405-HSG (N.D. Cal. Sep. 17, 2021)

Opinion

4:17-cv-04405-HSG

09-17-2021

PLEXXIKON INC, Plaintiff, v. NOVARTIS PHARMACEUTICALS CORPORATION, Defendant.


ORDER ON ADMINISTRATIVE MOTION TO EXCEED PAGE LIMITS

HON.HAYWOOD S. GILLIAM JR.UNITED STATES DISTRICT JUDGE

Pursuant to the parties' Joint Administrative Motion to Exceed Page Limits and their Stipulation submitted in support thereof, the Court finds good cause to expand the page limits that would otherwise be applicable to Novartis' motion for judgment as a matter of law or a new trial/remittitur (see Dkt. 577). Accordingly, the motion is GRANTED, and it is HEREBY ORDERED that

Novartis may file an opening brief not to exceed forty (40) pages; Plexxikon may file an opposition brief not to exceed forth (40) pages; and Novartis may file a reply brief not to exceed twenty (20) pages.


Summaries of

Plexxikon Inc. v. Novartis Pharm. Corp.

United States District Court, Northern District of California
Sep 17, 2021
4:17-cv-04405-HSG (N.D. Cal. Sep. 17, 2021)
Case details for

Plexxikon Inc. v. Novartis Pharm. Corp.

Case Details

Full title:PLEXXIKON INC, Plaintiff, v. NOVARTIS PHARMACEUTICALS CORPORATION…

Court:United States District Court, Northern District of California

Date published: Sep 17, 2021

Citations

4:17-cv-04405-HSG (N.D. Cal. Sep. 17, 2021)